Brief: Cassava Sciences posts Q1 EPS USD -0.58
01/05/2023 14:26
May 1 (Reuters) - Cassava Sciences Q1 net income USD -24.271 million. * Q1 operating expenses USD 26.512 million * Q1 operating income USD -26.512 million * Q1 EPS USD -0.58
Recent news on Filana Therapeutics
See all newsCassava Sciences says US DOJ has closed investigation into company (updated)
Cassava Sciences rises after US DOJ closes probe into company
Cassava Sciences says US DOJ has closed investigation into company
Brief: Cassava Announces Agreement To Settle Securities Class Action Litigation
Brief: Cassava Sciences Inc - On Dec 15, FDA Places Full Clinical Hold On Cassava's Trial - SEC Filing